-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED ANNOUNCES SUBMISSION OF US NDA FOR ORPATHYS® PLUS TAGRISSO® IN MET-DRIVEN EGFR-MUTATED LUNG CANCER

Reuters·09/29/2026 00:01:02